Compassionate Care Application
Read More
Resource Library
-
-
A Journey to 22q11.2 Deletion Syndrome Diagnosis
Watch Video
-
Oncology Patient Signatera Requisition Form
Read More
-
ASTS 2022 Symposium: Optimized cfDNA - Prospera with Two Threshold Algorithm
Watch Video
-
Have a question or comment?
Contact Us -
ISHLT 2022 Symposium: Calibrating donor-derived cell-free DNA levels against tissue Molecular Phenotyping
Watch Video
-
Asco 2022 Monitoring Efficacy of Neoadjuvant Sunitinib in Metastatic Renal Cell Carcinoma
Read More
-
Prospera Surveillance Testimonial with Dr. Obi Ekwenna
Watch Video
-
Nature Cancer Summary: ctDNA as an early predictor of therapy response
Read Publication
-
Guiding Melanoma Risk Assessment
The post Guiding Melanoma Risk Assessment appeared first on Natera.
Read Article
-
Webinar: ctDNA as a predictive biomarker for immunotherapy response
Watch Video
-
Why Screening for Lynch Syndrome is Important
The post Why Screening for Lynch Syndrome is Important appeared first on Natera.
Read Article
-
ASCO GU 2022 Molecular residual disease (MRD) detection with a tissue comprehensive genomic profiling (CGP)-informed personalized monitoring
Read More
-
Findings from the first 1,000 tests using the Renasight™ test’s broad kidney gene panel
Read Article
-
KDIGO Executive Conclusions Paper Urges Clinicians to ‘Think Genetic’
Read Article
-
Optimizing the management of patients with solid tumors using a tumor-informed approach
Watch Video
-
Signatera Breast Cancer Data Sheet
Read More
-
Serial postoperative ctDNA monitoring of breast cancer recurrence
Read More
-
Comparison of the predictive and prognostic significance of circulating tumor DNA
Read More
-
Personalized Circulating tumor DNA as a Predictive Biomarker in High-Risk Early Stage Breast Cancer Treated With Neoadjuvant Chemotherapy
Read More
-
A Genetic Counselor Helps a Couple Navigate Growing a Family
Read Article
-
Loading More...
